In Russia began to use the domestic vaccine against colon cancer
In Russia, the clinical use of a colon cancer vaccine called Oncopept began.

In Russia, the clinical use of a colon cancer vaccine called Oncopept began. This was announced by Deputy Head of the Federal Medical and Biological Agency (FMBA) of Russia Igor Borisevich, speaking at the session of the Congress “Innovative Practice: Science Plus Business”.
“A vaccine based on neoantigens of cancer cells in a particular patient has been developed, registered and is now used clinically,” Borisevich said.
As previously told Veronika Skvortsova, head of the FMBA of Russia, specialists of the Federal scientific and clinical center, engaged in the development of the vaccine, identified specific mutations that have become “identifying signs” of cancer cells. On their basis, a personal set of peptides (very short sections of proteins) was created. "When administered to a patient, these peptides train the immune system to accurately recognize and destroy tumor cells, triggering a targeted antitumor response," she explained.
The Ministry of Health issued a permit for the clinical use of Oncopept on November 20, 2025. In April 2026, Prime Minister Mikhail Mishustin announced that Russians will be able to receive treatment with the use of oncological vaccines free of charge under the compulsory medical insurance system. The MHI system has since incorporated personalized treatments, including the Oncopept vaccine.



